(Q30823309)

26 June 2017

1 reference

title

Latest maintenance data on lamotrigine in bipolar disorder (English)

1 reference

26 June 2017

1 reference

1 reference

Eduard Vieta

2

0 references

Joseph R Calabrese

series ordinal

1

object named as

Joseph R Calabrese

1 reference

26 June 2017

Melvin D Shelton

3

1 reference

26 June 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

European Neuropsychopharmacology

26 June 2017

published in

1 reference

26 June 2017

volume

13 Suppl 2

1 reference

26 June 2017

page(s)

S57-66

1 reference

Mortality of patients with mood disorders: follow-up over 34-38 years

26 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900079-8

7 January 2021

Toward a re-definition of subthreshold bipolarity: epidemiology and proposed criteria for bipolar-II, minor bipolar disorders and hypomania.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900079-8

7 January 2021

A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900079-8

7 January 2021

A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900079-8

7 January 2021

Rash in multicenter trials of lamotrigine in mood disorders: clinical relevance and management.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900079-8

7 January 2021

A Double-Blind, Placebo-Controlled, Prophylaxis Study of Lamotrigine in Rapid-Cycling Bipolar Disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900079-8

7 January 2021

A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900079-8

7 January 2021

A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900079-8

7 January 2021

A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900079-8

7 January 2021

Lamotrigine-associated rash: risk/benefit considerations in adults and children

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900079-8

7 January 2021

Rash in adult and pediatric patients treated with lamotrigine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900079-8

7 January 2021

Lamotrigine as adjunct to paroxetine in acute depression: a placebo-controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900079-8

7 January 2021

10.1016/S0924-977X(03)00079-8

Identifiers

DOI

1 reference

26 June 2017

1 reference